glp 1 latest news GLP-1 drugs promise wider health benefits, but experts urge caution on use π¨ Big news for people
Description
Schedule a free GLP-1 consultation and save 20% off your first treatment.
A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.
Agents such as dulaglutide, liraglutide, semaglutide, and tirzepatide differ in pharmacology and dosing, directly influencing perioperative safety, particularly due to their effects on gastric motility and the high frequency of gastrointestinal (GI) adverse events that raise concerns about aspiration and postoperative morbidity in urgent or elective procedures
Clinically, that translates to: More stable post-meal glucose Better appetite regulation Reduced energy crashes Improved satiety Mechanistically: GLP-1 slows gastric emptying, signals fullness centrally, supports insulin secretion, and suppresses glucagon
Chandler, AZ
